{"id":279865,"date":"2024-10-19T18:53:47","date_gmt":"2024-10-19T18:53:47","guid":{"rendered":"https:\/\/pdfstandards.shop\/product\/uncategorized\/bs-en-iso-11607-12017-tc\/"},"modified":"2024-10-25T15:28:30","modified_gmt":"2024-10-25T15:28:30","slug":"bs-en-iso-11607-12017-tc","status":"publish","type":"product","link":"https:\/\/pdfstandards.shop\/product\/publishers\/bsi\/bs-en-iso-11607-12017-tc\/","title":{"rendered":"BS EN ISO 11607-1:2017 – TC"},"content":{"rendered":"
PDF Pages<\/th>\n | PDF Title<\/th>\n<\/tr>\n | ||||||
---|---|---|---|---|---|---|---|
1<\/td>\n | compares BS EN ISO 11607-1:2017 <\/td>\n<\/tr>\n | ||||||
2<\/td>\n | TRACKED CHANGES Test example 1 <\/td>\n<\/tr>\n | ||||||
3<\/td>\n | BS EN ISO 11607-1:2017 to BS EN ISO 11607-1:2009 <\/td>\n<\/tr>\n | ||||||
5<\/td>\n | National foreword Compliance with a British Standard cannot confer immunity from legal obligations. Amendments\/corrigenda issued since publication <\/td>\n<\/tr>\n | ||||||
7<\/td>\n | ForewordEuropean foreword Table \u2014 Correlation between normative references and dated EN and ISO standards <\/td>\n<\/tr>\n | ||||||
9<\/td>\n | Annex ZA (informative) <\/td>\n<\/tr>\n | ||||||
10<\/td>\n | Table ZA.1 \u2014 Correspondence between this European Standard and Annex I of Directive 93\/42\/EEC [OJ L 169] <\/td>\n<\/tr>\n | ||||||
12<\/td>\n | Annex ZB (informative) Table ZB.1 \u2014 Correspondence between this European Standard and Annex I of Directive 90\/385\/EEC [OJ L 189] <\/td>\n<\/tr>\n | ||||||
14<\/td>\n | Annex ZC (informative) Table ZC.1 \u2014 Correspondence between this European Standard and Annex I of Directive 98\/79\/EC [OJ L 331] <\/td>\n<\/tr>\n | ||||||
17<\/td>\n | Foreword <\/td>\n<\/tr>\n | ||||||
18<\/td>\n | Introduction <\/td>\n<\/tr>\n | ||||||
19<\/td>\n | Packaging for terminally sterilized medical devices \u2014 1 Scope 2 Normative references 3 Terms and definitions 3.1 aseptic presentation introduction and transfer of a sterile product using conditions and procedures that exclude microbial contamination 3.2 bioburden population of viable microorganisms on or in a product or sterile barrier system [SOURCE: ISO\/TS 11139:2006] <\/td>\n<\/tr>\n | ||||||
20<\/td>\n | 3.3 3.4 3.5 3.6 3.7 3.8 <\/td>\n<\/tr>\n | ||||||
21<\/td>\n | 3.9 3.10 3.11 3.12 3.13 3.14 3.15 <\/td>\n<\/tr>\n | ||||||
22<\/td>\n | 3.16 3.17 3.18 3.19 3.20 3.21 3.22 <\/td>\n<\/tr>\n | ||||||
23<\/td>\n | 3.23 3.24 3.25 3.26 3.27 3.28 3.29 4 General requirements 4.1 General 4.2 Quality systems <\/td>\n<\/tr>\n | ||||||
24<\/td>\n | 4.3 Sampling 4.4 Test methods 4.5 Documentation <\/td>\n<\/tr>\n | ||||||
25<\/td>\n | 5 Materials and preformed sterile barrier systems 5.1 General requirements <\/td>\n<\/tr>\n | ||||||
27<\/td>\n | 5.2 Microbial barrier properties <\/td>\n<\/tr>\n | ||||||
28<\/td>\n | 5.3 Compatibility with the sterilization process 5.4 Compatibility with the labelling system <\/td>\n<\/tr>\n | ||||||
29<\/td>\n | 5.5 Storage and transport 6 Design and development requirements for packaging systems 6.1 General 6.2 Design <\/td>\n<\/tr>\n | ||||||
30<\/td>\n | 6.3 Packaging-system performance testing <\/td>\n<\/tr>\n | ||||||
31<\/td>\n | 6.4 Stability testing 7 Information to be provided <\/td>\n<\/tr>\n | ||||||
32<\/td>\n | (informative) A.1 Factors influencing the choice of the materials and design of the packaging system Figure A.1 \u2014 Interrelationships influencing the choice of appropriate materials for terminally sterilized medical packaging systems A.3 Sterile barrier systems <\/td>\n<\/tr>\n | ||||||
35<\/td>\n | Annex B (informative) B.1 General B.2 Packaging materials and preformed sterile barrier systems Table B.1 \u2014 Test methods and their status <\/td>\n<\/tr>\n | ||||||
47<\/td>\n | Annex C (normative) <\/td>\n<\/tr>\n | ||||||
48<\/td>\n | Bibliography <\/td>\n<\/tr>\n | ||||||
52<\/td>\n | undefined <\/td>\n<\/tr>\n | ||||||
56<\/td>\n | Annex ZA (informative)Relationship between this European Standard and the essential requirements of Directive 93\/42\/EEC [OJ L 169] aimed to be covered <\/td>\n<\/tr>\n | ||||||
58<\/td>\n | Annex ZB (informative)Relationship between this European Standard and the essential requirements of Directive 90\/385\/EEC [OJ L 189] aimed to be covered <\/td>\n<\/tr>\n | ||||||
60<\/td>\n | Annex ZC (informative)Relationship between this European Standard and the essential requirements of Directive 98\/79\/EC [OJ L 331] aimed to be covered <\/td>\n<\/tr>\n | ||||||
63<\/td>\n | undefined <\/td>\n<\/tr>\n | ||||||
64<\/td>\n | undefined <\/td>\n<\/tr>\n | ||||||
65<\/td>\n | undefined undefined undefined <\/td>\n<\/tr>\n | ||||||
69<\/td>\n | undefined undefined undefined <\/td>\n<\/tr>\n | ||||||
70<\/td>\n | undefined undefined undefined <\/td>\n<\/tr>\n | ||||||
71<\/td>\n | undefined undefined <\/td>\n<\/tr>\n | ||||||
73<\/td>\n | undefined <\/td>\n<\/tr>\n | ||||||
74<\/td>\n | undefined undefined <\/td>\n<\/tr>\n | ||||||
75<\/td>\n | undefined undefined undefined undefined <\/td>\n<\/tr>\n | ||||||
76<\/td>\n | undefined <\/td>\n<\/tr>\n | ||||||
77<\/td>\n | undefined undefined <\/td>\n<\/tr>\n | ||||||
78<\/td>\n | undefined <\/td>\n<\/tr>\n | ||||||
81<\/td>\n | undefined <\/td>\n<\/tr>\n | ||||||
90<\/td>\n | undefined <\/td>\n<\/tr>\n | ||||||
91<\/td>\n | undefined <\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":" Tracked Changes. Packaging for terminally sterilized medical devices – Requirements for materials, sterile barrier systems and packaging systems<\/b><\/p>\n |